Forskningsfinansiering från USA
Karolinska Institutet är den största mottagaren av extern forskningsfinansiering från USA bland svenska universitet. År 2023 bidrog amerikanska finansiärer med närmare 110 miljoner kronor till KI:s forskning. Intäkterna kom från både federala finansiärer som National Institutes of Health (NIH) och privata stiftelser i landet.
Årtal | Statliga finansiärer | Privata stiftelser | Totalt |
---|---|---|---|
2013 | 21,3 | 45,6 | 66,9 |
2014 | 22,5 | 46,1 | 68,6 |
2015 | 32,8 | 42,4 | 75,2 |
2016 | 40,6 | 38,2 | 78,8 |
2017 | 41,3 | 32,3 | 73,6 |
2018 | 50 | 45 | 95 |
2019 | 52,1 | 44,5 | 96,6 |
2020 | 40 | 58,2 | 98,2 |
2021 | 50 | 51.3 | 101.3 |
2022 | 53.3 | 49.4 | 102.7 |
2023 | 64 | 46.2 | 110.2 |
Federala statliga anslag till enskilda forskningsprojekt
CDC (Centers for Disease Control and Prevention) - 2021
- Fang Fang (R01/Prime) - Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis - A Unique Contribution from Sweden
Anna Norrby-Teglund (R01/Sub) Assays for acceleration: from fit-for-purpose models to scalable assays of broad systemic and mucosal protection against all strains of Group A Streptococcus
- Malin Ernberg (UC2/Sub) Comprehensive functional phenotyping of trigeminal neurons innervating temporomandibular joint (TMJ) tissues in male female and aged mice primates and humans with and without TMJ disorders (TMJD)
- Josefin Särnholm (P30/Sub) Columbia Roybal Center for fearless behavior change
- Rickard Sandberg (U01/Sub) Comprehensive single-cell atlas of the developing mouse brain
- Sten Linnarsson and Rickard Sandberg (UM1/Sub) Functionally guided adult whole brain cell atlas in human and NHP
- Sara Hägg (R01/Prime) - Repurposing drugs for Alzheimer´s disease using a reverse translational approach
- Alek Erickson (F32/Prime) - Signaling mechanisms underlying neural crest cell fate decisions
- Mikael Karlsson (R01/Sub) - Engaging immunosuppressive myeloid cells in the TME for the treatment of pancreatic cancer
- Ulrika Marklund (R01/Sub) - Neurobiology of Intrinsic Primary Afferent Neurons
- Petter Brodin (U01/Sub) - Enhancing immunity to malaria in young children with effective chemoprevention
- Ingrid Lundberg (R21/Sub) - Extracellular mitochondria in Inclusion Body Myositis
- Gunilla Karlsson Hedestam (P01) – HIV vaccine research and design
- Lars Terenius (R01/Prime) – Drug targeting the dynamics of opioid systems in alcohol dependence
- Anna Marseglia (R24/Sub) – Developing a biological marker of cognitive reserve with deep learning from multimodal structural MRI
- Nina Bohm-Starke (R21/Sub) – Risk of vulvodynia due to immune-related health events throughout the life course
- Yi Lu (R01/Sub) – A Trans-Nordic Study of Extreme Major Depression
- Sarah Bergen (R01/Prime) – A comparison of environmental and genetic risks for schizophrenia and bipolar disorder: A Swedish national study
- Ivan Nalvarte (R01/Prime) – Understanding the role of menopause and estrogen receptor activation for Alzheimer's disease risk
- Elizabeth Arkema (R01/Sub) – Can hydroxychloroquine prevent preeclampsia and preterm delivery in lupus pregnancy?
- Sara Öberg (R01/Sub) – Maternal use of prescribed opioid analgesics and risk of adverse offspring outcomes
- Gunilla Karlsson Hedestam (P51/Sub) – Support of Yerkes National Primate Research Center
- Karl Eriksson (U01/Sub) – STABILITY 2: ACL Reconstruction +/- Lateral Tenodesis with Patellar vs. Quad Tendo
- Sven Cnattingius (R21/Sub) – Prenatal and Neonatal Risk Factors for Adverse Neurodevelopmental Outcomes in Childhood and Early Adulthood
- Gunilla Karlsson Hedestam (UM1/Sub) – Consortium for HIV/AIDS Vaccine Development
- Cecilia Magnusson (R01/Sub) – Maternal epilepsy, antiepileptic drug use during pregnancy, and risk of autism'
- Benjamin Murrell (UM1/Sub) – HVTN Laboratory Center
Sarah Bergen (R21/Prime) – Schizophrenia Comorbidities: Common Genes and Clusters
- Tatiana Deliagina (R01/Sub) – Neural Mechanisms of Locomotion Evoked by Epidural Stimulation of the Spinal Cord
- Johan Grunewald (R01/Sub) – T cell epitopes in sarcoidosis
- Rickard Sandberg (R01/Sub) – Deciphering the building blocks of hippocampal circuits
- Maria Sabater Lleal (R01/Sub) – Population genomic variation, functional biology, and the risk of venous thrombosis
- Rickard Sandberg (U19/Sub) – A comprehensive whole-brain atlas of cell types in the mouse
- Sten Linnarsson (U01/Sub) – A multimodal atlas of human brain cell types
- Barbara Canlon (R56/Prime) – Circadian regulation of glucocorticoid-dependent inflammation in noise-induced synaptopathy
- Michael Yi Bonner (F31/Prime) – Redox modulation - Impact on Tumor Growth and Therapeutic Anticancer Efficacy
- Ivanka Savic-Berglund (R01/Sub) – Gender identity and own body perception implications for the neurobiology of gender dysphoria
- Gunilla Karlsson Hedestam (U01/Sub) – Immunoglobulin gene diversity in an African population and impact on antibody function in HIV infection
- Ahmed Elewa (F32/Prime) – Discovering signature genes and developing expression markers for blastema cells
- David Mataix-Cols (R01/Sub) – OCD: Novel Comparative Genomic Approaches to Identify Disease and Treatment Mechanisms.
- Elias Arnér (R21/Sub) – Redox regulation in the hepatostat.
- Fredrik Wiklund (R01/Sub) – The Genetic Basis of Aggressive Prostate Cancer: The Role of Rare Variation.
- Konstantinos Meletis (R21/Sub) – Development of a whole-brain cellular mapping approach in a genetic model of autism and intellectual disability.
- Nancy Pedersen (R56/Sub) – Gene-Environment Interplay of Social contexts and Aging-Related Outcomes.
- Ujjwal Neogi (R01/Sub) – Reverse Transcriptase Multi-Class Drug Resistance and Rilpivirine Susceptibility in Diverse HIV-1 Subtypes.
Department of Defense (DoD)
2021: Camilla Svensson (CDMRP/Sub) - Fc gamma receptor signaling: a new pathway for sustained neuropathic pain
2020 - Samir EL Andaloussi (CDMRP/Prime) - Muscle-Targeted Cell-Penetrating Peptides for Delivery of Cas9-RNPs and Modified mRNA to Dystrophic Muscle
2017: Helena Ledmyr (Office of Naval Research) – CSP – The 10th Neuroinformatics Congress of the International Neuroinformatics Coordinating Facility (INCF)
2016: Barbara Canlon (CDMRP/Prime) – Chronopharmacological Interventions for the Successful Treatment of Noise-Induced Hearing Loss.
2015: Theresa Vincent (CDMRP/Sub) – Targeting Breast Cancer Metastasis through Selective Inhibition of RNA Polymerase I.
Finansiering från privata stiftelser till enskilda forskningsprojekt
2020
Bill & Melinda Gates Foundation:
- Karin Loré (Prime) – COVID-19: NHP Study of Novavax nanoparticle at Karolinska.
- Anna Smed Sörensen – (Prime) - COVID-19: blood and airway disease in Sweden.
- Karin Loré (Prime) – Immunogenicity study of CureVac’s mRNA vaccine for Covid-19 in rhesus macaques.
- Helena Lindgren – Maternal and child health-care in Sub-Saharan African countries.
2018
Bill & Melinda Gates Foundation: Karin Loré (Prime) – Analyse the immune responses elicited by novel mRNA-based vaccines.
2017
Bill & Melinda Gates Foundation: Karin Loré (Sub) – Structure Based Immunogen Design at UWIPD.
2016
Jeffrey Modell Foundation: Lennart Hammarström (Sub)
Patient-Centered Outcomes Research Institute (PCORI): Fredrik Piehl (Prime) – Rituximab in Multiple Sclerosis: A Comparative Study on Effectiveness, Safety, and Patient-Reported Outcomes. Läs mer på KI Nyheter
2015
Bill & Melinda Gates Foundation:
CHDI Foundation Inc: Christer Halldin
The Myositis Association: Ingrid Lundberg
The Vallee Foundation: Rickard Sandberg (Vallee Scholar) – The nature of allelic gene expression in vivo.